This CTD dossier owner and manufacturer specializes in manufacturing both generic and branded pharmaceuticals, boasting a 30-year track record of quality production. Their state-of-the-art facilities are strategically located within an industrial zone in Southeast Asia, allowing them to produce a wide range of products across various therapy areas, including prescription medications, over-the-counter drugs, and potentially medical devices or supplements (information on these is limited). While specific product patents and GMP certifications aren't mentioned, their commitment to quality manufacturing is evident. They operate primarily in Southeast Asia, with potential expansion into other regions like North America and the EU based on industry trends.
Guaifenesin, an expectorant, helps loosen congestion in chest and throat, making it easier to cough out thick mucus or phlegm from the airways. It is also combined with dextromethorphan, a cough suppressant or with ephedrine to medicines for symptomatic relief from asthma. Overall, it is used to reduce chest congestion caused by the common cold, infections, or allergies. Its actions as an expectorant it keeps the respiratory tract effectively hydrated and maintains the sol layer that is needed for ciliary clearance. It also reduces the viscosity of respiratory mucus, which makes it easy for the body to expel the mucus or phlegm more easily in the natural body process.
Guaifenesin is sold under the brand name Mucinex among others. Guaifenesin is extracted from a tree bark extract called guaiacum. This bark has historically been used as an expectorant in the Caribbean region and adopted by European explorers in the 16the century. But it was not till 1952, that the first medical preparations got their approvals from the FDA in the USA. However, it took a further 20 years before, it was synthesized into tablets for medication.